16 May 2024
16 May 2024
There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.
Highly potent active pharmaceutical ingredients (HPAPIs) are essential for chemotherapies and combination therapies. With specialised production facilities in great demand, what are the key challenges in HPAPI manufacturing?
The approval is based on results from the open-label, global, multi-centre, single-arm Phase II TRANSCEND FL clinical trial.
The TAK-003 vaccine targets all four virus serotypes.
The US agency rejected the expanded use of Dynavax’s vaccine for adults on haemodialysis, citing insufficient efficacy and safety data.
The US National Opioid Settlement is distributing more than $54 billion to communities grappling with the opioid crisis.
The BLA was delayed from earlier this year when the FDA requested additional data.
Several companies have announced data presentations at the 2024 ASCO annual meeting for their late-stage and approved programs.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
